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INTRODUCTION: We present a rare patient case with mixed gonadal dysgenesis as a disorder of sex
development (DSD) and a new pattern of chromosome in the karyotype, 45, X/46, X, +mar(Y).
PRESENTATION OF CASE: A ten-year-old boy, raised in a nursery center, presented with ambiguous
genitalia. Two cell lines, (45, X) and [46,X, +mar(Y)] were observed utilizing cytogenetic investigation
including fluorescence in situ hybridization (FISH) which were carried out on his peripheral lympho-
cytes. A significantly higher percentage (75%) of Y-containing cells was observed in the blood, which
could be considered the major reason why the case did not have distinct ambiguous genitalia. A fur-
ther explorative laparoscopic procedure was performed, during which orchiectomy was performed, and
remnants of Müllerian duct were excised.
DISCUSSION:Acomplete and sufficiently carefulmedical evaluationandgenetics counselingofneonates is
highly recommended in order to avoid any delayed insufficient diagnostic, conservative, and therapeutic
care in children livingwith guardians rather than their biological parents. Bothmolecular and cytogenetic
studies are recommended in some DSDs to help early diagnosis of the disease, which is important for
further essential surgical approaches.
CONCLUSION: Cytogenetic studies followed by a laparoscopic exploratory and surgical survey are helpful
tools for unraveling the mosaicism involving sex chromosomes and the complicated process in mixed
gonadal dysgenesis patients.
© 2014 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Gonadal dysgenesis refers to a variety of clinical conditions
in which abnormal development of the fetal gonad is present. It
consists of 46, XY gonadal dysgenesis, mixed gonadal dysgenesis
(MGD), and 45, X Turner syndrome [1]. MGD, a disorder of sex
development (DSD), is defined in individuals who typically have
a differentiated gonad on one side and a streak gonad or streak
Abbreviations: MGD, mixed gonadal dysgenesis; mark, mar; TH, true
hermaphroditism; AMH, anti-Müllerian hormone; UDT, undescended testis; SRY,
sex determined region of Y chromosome; kg, kilogram; cm, centimeter; EMS,
external masculinization scores; HRT, hormone replacement therapy; HCG, human
chorionic gonadotropin; IGF-I, insulin like grows factor 1; PCR, polymerase chain
reaction; GTG, generate test generator; MPH, mid-parental height; GH, growth hor-
mone.
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testis (usually intra-abdominal) on the other side. Persistent Mül-
lerian structures such as the ovary or uterus may also be present
[2]. However, true hermaphroditism (TH) cases have both unequiv-
ocal ovarian tissue and testicular elements independent to their
karyotypes. TH and MGD should be differentiated, and a counsel-
ing physician should be consulted to decide for early gonadectomy
in MGD to prevent the high risk of malignancy [3,4].
Sex chromosome mosaicism (45, XO/46, XY) is the most com-
mon karyotype expressed in MGD and may cause formation of
a dysgenetic or malformed gonad. This is referred to as a streak
gonad that does not produce enough testosterone [2,5]. Ambigu-
ous genitalia is the most common presentation for individuals
with a 45X/46XY karyotype accounting for about 60% of involved
individuals [6]. In clinical examination, undescended testis (crypt-
orchidism) and/or hypospadias may be found. For this reason, a
chromosomal study via karyotyping is necessary to be done for any
patient with penoscrotal hypospadias and undescended testis [7].
Measurement of the level of anti-Müllerian hormone (AMH),which
is usually insufficient in dysgenetic gonad, can also help us to dif-
ferentiate any type of intersexual condition [8]. In these conditions,
thepatients have female reproductiveorgans suchas ahemi-uterus
http://dx.doi.org/10.1016/j.ijscr.2014.12.011
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Table 1
The results of the patient’s serum tests.
No Lab test:
1 FSH-ECL 1.76mlU/ml
2 FSH/LH Ratio 14.67mIU
3 LH-ECL 0.12mIU LOW
4 Testosterone <.025ng/ml LOW
5 17OH-Prog 0.25ng/mlu
6 DHEA-SO4, ECL 26.7Micg/dl
7 Androstendione-RIA 0.4ng/ml
8 A.C.T.H 8.5pg/ml
9 CORTISOL, ECL (AM) 14.5
10 WBC 4500
11 Hb 11.5
12 MCV 75.3
13 Blood sugar 79
14 Sodium 140
15 Potassium 4.4
Note: FSH: follicle-stimulating hormone, ECL: electrochemiluminescency, LH:
luteinizing hormone, 17OH-Prog: 17-hydroxy-progesterone, DHEA-SO4: dehy-
droepiandrosterone, RIA: radioimmunoassay, A.C.T.H: adrenocorticotropic hor-
mone, WBC: white blood cells, Hb: hemoglobin, MCV: mean corpuscular volume.
and fallopian tube in testicular dysgenesis [9]. Meanwhile, patients
with impaired testosterone secretion show the level of AMH either
within normal limit or slightly elevated [8].
Y chromosome behavior is a strong risk factor for germ cell
tumors [10]; however, hormone production via saving testis is very
varied and depends on each case individually [11–13].
The correlation of clinical phenotype in MGD with cancer risk
has been shown to be as high as 52% [12]. In mild MGD, spermato-
genesis may be impaired in adulthood, resulting in infertility or
subfertility. However in more severe MGD, testicular cancer may
be observed at a younger age [6,14].
We present a rare case with MGD and a new pattern of chromo-
some in the karyotype, 45, X/46, X, +mar(Y).
2. Case presentation
A ten-year-old boywas referred to the pediatrics clinic of Hazrat
Rasul Akram Hospital with left-sided cryptorchidism, penoscrotal
hypospadias, and growth retardation. His height was 118.7 cm, and
his body weight was 22kg (25th Percentile). He was raised in a
nursery center as a result of his father’s incompetence and some
family problems,whichmight be the reasonwhy he had not sought
any medical advice earlier. His physical examination consisted of
a significant short stature, low-set hair line, a gonadal phenotype
similar to male genitalia with hypospadias, chordee penis, and a
left-sided undescended testis (UDT). In karyotype, 20 metaphases
were assessed on the basis of GTG technique at 450–500 band res-
olution including five plates (25%) of 45X, and the remaining plates
(75%) revealed 46 chromosomes with a small marker chromosome
(45, X [5]/46, X, +mar [15]. Thus, a molecular study was planned
to determine the origin of the marker chromosome. In the molec-
ular study, DNA was extracted from peripheral blood leukocytes to
seek the sex-determined regionof theY chromosome (SRY) geneby
PCR technique. The specific probes for X and Y chromosomes were
also applied to approach the origin of the marker in a FISH study.
These results revealed presence of both X and Y chromosomes and
SRY genes which were compatible with a male phenotype. The
laboratory tests are included in Table 1.
Ultrasound examination revealed no left testis in the scrotum
or inguinal canal, and no sign of remnants of Müllerian struc-
tures, such as the uterus, was appreciated. After counseling with
the patient, his family, and pediatric psychologist, the decision
was made to pronounce the patient male gendered. Subsequently,
explorative laparoscopy was offered, and left testis was seen on
the left internal ring. In addition, the fallopian tube and a single
Fig. 1. Intra-abdominal testis.
Fig. 2. Fallopian tube.
ovary were seen on the same side, but no uterus was observed.
(Figs. 1 and 2) In the next step, laparoscopy orchiectomy was
performed, and remnants of Müllerian duct were excised. In a
histopathologic review of specimen, streak ovary, fallopian tube,
and testiswere confirmed. The patientwas referred for urology and
endocrinology evaluation, and a trial of GH therapy for treatment
of short stature was considered.
3. Discussion
Sex chromosomal mosaicism is the common karyotype in MGD.
Johansenandcoworkers reported structural rearrangementof theY
chromosome in 63% of MGD patients [15,16]. However, normal XY
karyotype was reported by Anand et al. [17]. In our case, mosaic
chromosomal pattern with a chromosome marker was found.
Therefore, PCRwasperformed for the sex-determining regionof the
Y chromosome (SRY) upon proposal of MGD as the primary diag-
nosis. Most MGD cases require corrective surgery because of the
two mismatched gonads. In case of the decision to convert to male
gender, female ductal structures should be removed. If the child’s
phallus is small, she would function better as a female; therefore,
the testis should be removed [2,5,15]. Normal right side testis in our
patient produced adequate testosterone to enhance puberty and
body shape formation. In addition, the patient was raised as a male,
and he preferred to stay as such. Although there is no exact predic-
tion of tumor risk in normal appearing males with mosaic (45X,
46XY) karyotype, tumor risk was anticipated low in our patient
due to normal testicular differentiation and maturation process
present in the clinical manifestation, including a normal external
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masculinization score (EMS) and bilaterally descended testes [18].
Therefore, according to this observation, we decided to preserve
our patient’s right testis with close follow-up in order to prevent
gonadoblastoma formation.
However, early diagnosis and evaluation is very important for
preventing psychological sequels as well as ruling out other abnor-
malities. Meanwhile, a complete and sufficiently careful medical
evaluation and genetics counseling of neonates referred to nurs-
eries is highly recommended to avoid any delayed and insufficient
diagnostic, conservative, therapeutic, and psychological care in
children with guardians rather than their biological parents. These
also include exclusion other congenital and/or genetic abnormali-
ties such as congenital adrenal hyperplasia.
Johansen et al. reported an adequate gonadal function in male
gender to produce pubertal phase. They showed that EMS, defined
by Ahmed et al. [19], acts as a sign of clinically malfunction-
ing gonads in patients with a very low EMS [15]. Phonotypical
males with a 45, X/46, XY karyotype and its variants assume to
have normal testicular function and spontaneous puberty even in
patientswith ambiguous genitalia [18,20]. However, some patients
mightneedhormone replacement therapy (HRT) after spontaneous
pubertal onset [20]. In male patients with MGD, the cause of infer-
tility is UDT and dysgenetic testis.
The prevalence of growth retardation is high although it seems
not to be due to growth hormone (GH) deficiency. In our case, trial
of GH therapy for was considered treatment of short stature.
Providing a multidisciplinary approach to managing these chil-
dren is crucial, like our medical team, which included a pediatric
endocrinologist, genetics counselor, laparoscopic surgeon, andpsy-
chologist.
4. Conclusion
Patients with mixed gonadal dysgenesis have a different
presentation and variant of chromosomal abnormalities. A mul-
tidisciplinary approach is necessary and crucial for early diagnosis
and proper management of these patients in order to prevent men-
tal and social sequels.
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